On Monday, Shares of Petróleo Brasileiro S.A. - Petrobras (NYSE:PBR), lost -6.02% to $6.25, as oil prices fell to a four-month low Monday on concerns about a selloff in Chinese stock markets and raised oil drilling in the U.S.
Light, sweet crude for September delivery settled down 75 cents, or 1.6%, at $47.39 a barrel on the New York Mercantile Exchange, the lowest settlement since March 20. WSJ Reports.
Petróleo Brasileiro S.A. Petrobras operates as an integrated energy company in Brazil and internationally. Its Exploration and Production segment engages in the exploration, development, and production of crude oil, natural gas liquids, and natural gas; and sale of crude oil and oil products produced at natural gas processing plants in domestic and foreign markets.
Shares of Texas Instruments Inc. (NASDAQ:TXN), remained unchanged to $49.03, during its last trading session.
Texas Instruments stated second-quarter revenue of $3.23 billion, net income of $696 million and earnings per share of 65 cents.
Regarding the company’s performance and returns to shareholders, Rich Templeton, TI’s chairman, president and CEO, made the following comments:
- “Revenue declined 2 percent year over year, inclusive of notably weak demand in communications equipment and continued strong demand in automotive.
- “Even so, our core businesses of Analog and Embedded Processing, together, grew slightly year over year and comprised 85 percent of second-quarter revenue. Analog delivered its eighth successive quarter of year-over-year growth.
- “Gross margin of 58.2 percent was up 1 percentage point from a year ago, reflecting the diversity and longevity of our product portfolio, in addition to the efficiency of our manufacturing strategy.
Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers worldwide. It operates through two segments, Analog and Embedded Processing.
Finally, Amedica Corporation (NASDAQ:AMDA), ended its last trade with 4.66% gain, and closed at $0.77.
Amedica Corporation declared that it anticipates to report second quarter 2015 revenue in the range of $4.7 million and $4.9 million, as contrast to $4.7 million during the first quarter of 2015.
Cash and cash equivalents at June 30, 2015 totaled about $12.4 million, while net cash used in operating activities during the first half of 2015 reduced by about $3.0 million from the preceding year period.
These preliminary, unaudited financial results for the quarter ending June 30, 2015 are based on current expectations and are subject to quarter-end closing adjustments, actual results may differ.
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
